Health insurance startup Alan reaches €5B valuation

French health insurance startup Alan, founded in 2016, has achieved a €5 billion valuation, marking growth from €4.5 billion in 2024. Serving one million users and operating in France, Belgium, Spain, and Canada, Alan is focused on ambitious investments following a €100 million funding round. The company reports significant revenue growth and aims for $1.16 billion in annual recurring revenue by 2026, prioritizing expansion over immediate profitability.
Key Points
- Alan's valuation increased to €5 billion after a €100 million funding round.
- The company serves 1 million users, including employees, freelancers, and retirees.
- Total annual recurring revenue reached €785 million in 2025, a 53% increase from 2024.
- Alan is operationally profitable in France and actively expanding into Belgium, Spain, and Canada.
- The startup aims to reach $1.16 billion in ARR by 2026, focusing on growth rather than immediate profitability.
Relevance
- The decline of 30% in European unicorns highlights the challenges for tech startups.
- Alan's swift valuation growth reflects a trend of increased investment in health technology.
- Alan's expansion aligns with the 2025 IT trends of digital health solutions and insurance startups gaining ground.
Alan's continued growth and investment ambitions amidst a challenging startup landscape demonstrate a strong belief in the future of health technology, as it navigates profitability while expanding its offerings across multiple countries.
